Healthcare1 hour ago
Jubilant Pharmova Limited (jublpharma) Announces Oral Presentation of Preliminary Phase 1 Clinical Data for Jbi-802
Jubilant Pharmova Limited (JUBLPHARMA) announces preliminary Phase 1 clinical data for JBI-802 presented at 68th ASH Annual Meeting.